Market Cap 2.30M
Revenue (ttm) 3.34M
Net Income (ttm) -10.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -316.47%
Debt to Equity Ratio -4.95
Volume 57,600
Avg Vol 68,002
Day's Range N/A - N/A
Shares Out 1.40M
Stochastic %K 76%
Beta -0.24
Analysts Strong Sell
Price Target $13.25

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of metastatic melanoma; EVX-02, a DNA-based cancer vaccine that has completed Phase 1/2a trial to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, DNA-based cancer vaccine for the treatment of various cancers, including non-small...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 31 31 97 53
Website: evaxion.ai
Address:
Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark
Olsen71
Olsen71 Oct. 24 at 1:57 PM
$EVAX 6-7-8-9...... 20 🚀💪
0 · Reply
NoNoNoNoNoNoYesNo
NoNoNoNoNoNoYesNo Oct. 23 at 2:24 PM
$EVAX average at 9. Not buying more as it's already heavy bag. That being said, I can see it rocketing back up to 12 range in days based on recent price activity and updates on their products.
0 · Reply
veseli
veseli Oct. 23 at 11:23 AM
0 · Reply
Peaceouty
Peaceouty Oct. 22 at 8:15 PM
$EVAX missed chance. Too tight on the budget. Not enough p2 patients.
0 · Reply
Olsen71
Olsen71 Oct. 22 at 6:17 PM
0 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 5:04 PM
$EVAX the dilution was unexpected. I guess it tells a deal is not around the corner. I learned from the webcast they are likely discussing EVX01 with potential partners. Now we have ppl selling in some panic. I think this can continue to a market cap of 30-40million.
3 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 5:01 PM
$EVAX nice i am scooping up shares. Small bits.
1 · Reply
Olsen71
Olsen71 Oct. 22 at 3:44 PM
$EVAX Good webinar.. Exciting what such good results from your product can lead to 💪 Best results available right now in the treatment of melanoma, so I simply don't understand the low price right now, where the next few weeks can go and a price rocket 🚀 Well, just my opinion, we'll have to see what happens in the long run..
1 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 3:17 PM
$EVAX nice discussions in the phase 2 data webinar
1 · Reply
NoNoNoNoNoNoYesNo
NoNoNoNoNoNoYesNo Oct. 22 at 2:44 PM
$EVAX F Cancer. If that doesn't get a Like, I don't know what will.
0 · Reply
Latest News on EVAX
Evaxion A/S - Special Call

Sep 25, 2025, 11:07 AM EDT - 4 weeks ago

Evaxion A/S - Special Call


Evaxion out-licenses vaccine candidate EVX-B3 to MSD

Sep 25, 2025, 7:00 AM EDT - 4 weeks ago

Evaxion out-licenses vaccine candidate EVX-B3 to MSD


Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript

Aug 19, 2025, 3:29 PM EDT - 2 months ago

Evaxion A/S (EVAX) Q2 2025 Earnings Call Transcript


Evaxion finalizes agreement with EIB to convert debt into equity

Jul 11, 2025, 8:00 AM EDT - 3 months ago

Evaxion finalizes agreement with EIB to convert debt into equity


Evaxion receives grant funding to design new polio vaccine

Jun 3, 2025, 9:15 AM EDT - 5 months ago

Evaxion receives grant funding to design new polio vaccine


Evaxion to present at World Vaccine Congress

Apr 10, 2025, 8:00 AM EDT - 7 months ago

Evaxion to present at World Vaccine Congress


Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript

Apr 1, 2025, 11:21 AM EDT - 7 months ago

Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript


Evaxion announces closing of $10.8 million public offering

Jan 31, 2025, 4:05 PM EST - 9 months ago

Evaxion announces closing of $10.8 million public offering


Evaxion announces pricing of $10.8 million public offering

Jan 30, 2025, 8:00 AM EST - 9 months ago

Evaxion announces pricing of $10.8 million public offering


Evaxion announces completion of ADS ratio change

Jan 14, 2025, 4:05 PM EST - 10 months ago

Evaxion announces completion of ADS ratio change


Evaxion announces plan to implement ADS ratio change

Dec 30, 2024, 8:00 AM EST - 10 months ago

Evaxion announces plan to implement ADS ratio change


Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 11:43 AM EDT - 1 year ago

Evaxion Biotech A/S (EVAX) Q2 2024 Earnings Call Transcript


Olsen71
Olsen71 Oct. 24 at 1:57 PM
$EVAX 6-7-8-9...... 20 🚀💪
0 · Reply
NoNoNoNoNoNoYesNo
NoNoNoNoNoNoYesNo Oct. 23 at 2:24 PM
$EVAX average at 9. Not buying more as it's already heavy bag. That being said, I can see it rocketing back up to 12 range in days based on recent price activity and updates on their products.
0 · Reply
veseli
veseli Oct. 23 at 11:23 AM
0 · Reply
Peaceouty
Peaceouty Oct. 22 at 8:15 PM
$EVAX missed chance. Too tight on the budget. Not enough p2 patients.
0 · Reply
Olsen71
Olsen71 Oct. 22 at 6:17 PM
0 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 5:04 PM
$EVAX the dilution was unexpected. I guess it tells a deal is not around the corner. I learned from the webcast they are likely discussing EVX01 with potential partners. Now we have ppl selling in some panic. I think this can continue to a market cap of 30-40million.
3 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 5:01 PM
$EVAX nice i am scooping up shares. Small bits.
1 · Reply
Olsen71
Olsen71 Oct. 22 at 3:44 PM
$EVAX Good webinar.. Exciting what such good results from your product can lead to 💪 Best results available right now in the treatment of melanoma, so I simply don't understand the low price right now, where the next few weeks can go and a price rocket 🚀 Well, just my opinion, we'll have to see what happens in the long run..
1 · Reply
Manwiththeplan
Manwiththeplan Oct. 22 at 3:17 PM
$EVAX nice discussions in the phase 2 data webinar
1 · Reply
NoNoNoNoNoNoYesNo
NoNoNoNoNoNoYesNo Oct. 22 at 2:44 PM
$EVAX F Cancer. If that doesn't get a Like, I don't know what will.
0 · Reply
Sarahsanjose2
Sarahsanjose2 Oct. 22 at 2:39 PM
0 · Reply
baldaldo
baldaldo Oct. 22 at 12:55 PM
$EVAX Ugh.
0 · Reply
saunderswe
saunderswe Oct. 21 at 5:12 PM
$EVAX We invite you to attend our upcoming online webinar this Wednesday at 16:30 CEST / 10:30 AM EDT, where Professor Adnan Khattak will present and discuss the newly released two-year phase 2 clinical data from EVX-01, Evaxion’s AI-designed personalized cancer vaccine. Secure your spot by registering here: http://events.teams.microsoft.com/event/3a4a908e… https://x.com/evaxionbiotech/status/1980596126727155814?s=46&t=McwaX0VZVm9KX06Vzv6rcA
1 · Reply
Sarahsanjose2
Sarahsanjose2 Oct. 21 at 3:51 PM
$EVAX it does not move. Is it halted?
0 · Reply
NoNoNoNoNoNoYesNo
NoNoNoNoNoNoYesNo Oct. 21 at 2:16 PM
$EVAX 🤮
0 · Reply
anachartanalyst
anachartanalyst Oct. 20 at 8:11 PM
$EVAX https://anachart.com/wp-content/uploads/ana_temp/1760972525_soc-img.jpg
0 · Reply
Babyhuey
Babyhuey Oct. 20 at 3:09 PM
$EVAX Trying to guess where to enter here can be dangerous to your wealth, IMO. There are too many deals on the table and in the deck to play yet. Market cap and shares outstanding screaming waaaaaay undervalued at this price.
1 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 1:16 PM
Lake Street has updated their rating for Evaxion ( $EVAX ) to Buy with a price target of 11.
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 12:02 PM
HC Wainwright & Co. updates rating for Evaxion ( $EVAX ) to Buy, target set at 16.
0 · Reply
Manwiththeplan
Manwiththeplan Oct. 20 at 8:57 AM
$EVAX - pipeline is full with preclinical treatments - market cap 42 million - there are multiple talks about deals - enough cash for +- 2 year - till now they make all their milestones for this year - positive news about deals will send this upwards I sold 75% of my shares with a large profit. Now i am confident waiting for what is next. If this goes down more i ll buy more.
0 · Reply
AlwaysBeHumble
AlwaysBeHumble Oct. 19 at 11:30 PM
$IVDA $MSS $EVAX $EZGO VRME chart is looking to gap up tmr. This is a known runner, has shown before it can run to $5+. Same bullish setup, Plus news!
0 · Reply
Peaceouty
Peaceouty Oct. 19 at 7:16 PM
$EVAX Still under the radar.
0 · Reply